Literature DB >> 34184813

Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity.

Qing Meng1, Qiuqiang Gao1, Shebli Mehrazarin1, Kamonchanok Tangwanichgapong1, Yu Wang1, Yiming Huang2, Yutong Pan1, Samuel Robinson3, Ziwen Liu1, Amirali Zangiabadi4, Renate Lux5, Panos N Papapanou1, X Edward Guo3, Harris Wang2, Luke E Berchowitz6,7, Yiping W Han1,8,9.   

Abstract

Fusobacterium nucleatum (Fn) is a Gram-negative oral commensal, prevalent in various human diseases. It is unknown how this common commensal converts to a rampant pathogen. We report that Fn secretes an adhesin (FadA) with amyloid properties via a Fap2-like autotransporter to enhance its virulence. The extracellular FadA binds Congo Red, Thioflavin-T, and antibodies raised against human amyloid β42. Fn produces amyloid-like FadA under stress and disease conditions, but not in healthy sites or tissues. It functions as a scaffold for biofilm formation, confers acid tolerance, and mediates Fn binding to host cells. Furthermore, amyloid-like FadA induces periodontal bone loss and promotes CRC progression in mice, with virulence attenuated by amyloid-binding compounds. The uncleaved signal peptide of FadA is required for the formation and stability of mature amyloid FadA fibrils. We propose a model in which hydrophobic signal peptides serve as "hooks" to crosslink neighboring FadA filaments to form a stable amyloid-like structure. Our study provides a potential mechanistic link between periodontal disease and CRC and suggests anti-amyloid therapies as possible interventions for Fn-mediated disease processes.
© 2021 The Authors.

Entities:  

Keywords:  zzm321990Fusobacterium nucleatumzzm321990; FadA; amyloid; colorectal cancer; periodontal disease

Mesh:

Substances:

Year:  2021        PMID: 34184813      PMCID: PMC8406402          DOI: 10.15252/embr.202152891

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   9.071


  50 in total

1.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

Authors:  Mara Roxana Rubinstein; Xiaowei Wang; Wendy Liu; Yujun Hao; Guifang Cai; Yiping W Han
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

2.  Signal peptide of FadA adhesin from Fusobacterium nucleatum plays a novel structural role by modulating the filament's length and width.

Authors:  Stéphanie Témoin; Karen L Wu; Vivian Wu; Menachem Shoham; Yiping W Han
Journal:  FEBS Lett       Date:  2011-11-19       Impact factor: 4.124

3.  Identification and characterization of a novel adhesin unique to oral fusobacteria.

Authors:  Yiping W Han; Akihiko Ikegami; Chythanya Rajanna; Hameem I Kawsar; Yun Zhou; Mei Li; Hakimuddin T Sojar; Robert J Genco; Howard K Kuramitsu; Cheri X Deng
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

4.  The cytotoxic Staphylococcus aureus PSMα3 reveals a cross-α amyloid-like fibril.

Authors:  Einav Tayeb-Fligelman; Orly Tabachnikov; Asher Moshe; Orit Goldshmidt-Tran; Michael R Sawaya; Nicolas Coquelle; Jacques-Philippe Colletier; Meytal Landau
Journal:  Science       Date:  2017-02-24       Impact factor: 47.728

5.  Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum.

Authors:  Alexander Swidsinski; Yvonne Dörffel; Vera Loening-Baucke; Franz Theissig; Jens C Rückert; Mahmoud Ismail; Walter A Rau; Dagmar Gaschler; Michael Weizenegger; Sigmar Kühn; Johannes Schilling; Wolf V Dörffel
Journal:  Gut       Date:  2009-11-18       Impact factor: 23.059

6.  Term stillbirth caused by oral Fusobacterium nucleatum.

Authors:  Yiping W Han; Yann Fardini; Casey Chen; Karla G Iacampo; Victoria A Peraino; Jaime M Shamonki; Raymond W Redline
Journal:  Obstet Gynecol       Date:  2010-02       Impact factor: 7.661

7.  Laboratory maintenance of fusobacteria.

Authors:  Yiping W Han
Journal:  Curr Protoc Microbiol       Date:  2006-01

8.  Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples.

Authors:  Nicola Segata; Susan Kinder Haake; Peter Mannon; Katherine P Lemon; Levi Waldron; Dirk Gevers; Curtis Huttenhower; Jacques Izard
Journal:  Genome Biol       Date:  2012-06-14       Impact factor: 13.583

9.  Evolution of invasion in a diverse set of Fusobacterium species.

Authors:  Abigail Manson McGuire; Kyla Cochrane; Allison D Griggs; Brian J Haas; Thomas Abeel; Qiandong Zeng; Justin B Nice; Hanlon MacDonald; Bruce W Birren; Bryan W Berger; Emma Allen-Vercoe; Ashlee M Earl
Journal:  MBio       Date:  2014-11-04       Impact factor: 7.867

10.  Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer.

Authors:  Jakob Wirbel; Paul Theodor Pyl; Ece Kartal; Konrad Zych; Alireza Kashani; Alessio Milanese; Jonas S Fleck; Anita Y Voigt; Albert Palleja; Ruby Ponnudurai; Shinichi Sunagawa; Luis Pedro Coelho; Petra Schrotz-King; Emily Vogtmann; Nina Habermann; Emma Niméus; Andrew M Thomas; Paolo Manghi; Sara Gandini; Davide Serrano; Sayaka Mizutani; Hirotsugu Shiroma; Satoshi Shiba; Tatsuhiro Shibata; Shinichi Yachida; Takuji Yamada; Levi Waldron; Alessio Naccarati; Nicola Segata; Rashmi Sinha; Cornelia M Ulrich; Hermann Brenner; Manimozhiyan Arumugam; Peer Bork; Georg Zeller
Journal:  Nat Med       Date:  2019-04-01       Impact factor: 53.440

View more
  9 in total

1.  The Periodontal Pathogen Fusobacterium nucleatum Exacerbates Alzheimer's Pathogenesis via Specific Pathways.

Authors:  Hongle Wu; Wei Qiu; Xiaofang Zhu; Xiangfen Li; Zhongcong Xie; Isabel Carreras; Alpaslan Dedeoglu; Thomas Van Dyke; Yiping W Han; Nadeem Karimbux; Qisheng Tu; Lei Cheng; Jake Chen
Journal:  Front Aging Neurosci       Date:  2022-06-23       Impact factor: 5.702

Review 2.  Colorectal cancer: the facts in the case of the microbiota.

Authors:  Slater L Clay; Diogo Fonseca-Pereira; Wendy S Garrett
Journal:  J Clin Invest       Date:  2022-02-15       Impact factor: 14.808

Review 3.  More Than Just a Periodontal Pathogen -the Research Progress on Fusobacterium nucleatum.

Authors:  Yuanxin Chen; Zhijie Huang; Zhengming Tang; Yisheng Huang; Mingshu Huang; Hongyu Liu; Dirk Ziebolz; Gerhard Schmalz; Bo Jia; Jianjiang Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293

4.  Fusobacterium nucleatum Subspecies Differ in Biofilm Forming Ability in vitro.

Authors:  Maria Muchova; Dario L Balacco; Melissa M Grant; Iain L C Chapple; Sarah A Kuehne; Josefine Hirschfeld
Journal:  Front Oral Health       Date:  2022-03-15

Review 5.  Fusobacterium nucleatum: The Opportunistic Pathogen of Periodontal and Peri-Implant Diseases.

Authors:  Yanchi Chen; Tao Shi; Yiling Li; Linyang Huang; Derong Yin
Journal:  Front Microbiol       Date:  2022-03-11       Impact factor: 5.640

6.  Outer Membrane Vesicles From Fusobacterium nucleatum Switch M0-Like Macrophages Toward the M1 Phenotype to Destroy Periodontal Tissues in Mice.

Authors:  Gang Chen; Qiang Sun; QiaoLing Cai; HongWei Zhou
Journal:  Front Microbiol       Date:  2022-03-21       Impact factor: 5.640

7.  Phytogenic supplement containing menthol, carvacrol and carvone ameliorates gut microbiota and production performance of commercial layers.

Authors:  Yadav S Bajagai; Friedrich Petranyi; Sung J Yu; Edina Lobo; Romeo Batacan; Advait Kayal; Darwin Horyanto; Xipeng Ren; Maria M Whitton; Dragana Stanley
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

Review 8.  Periodontal microorganisms and Alzheimer disease - A causative relationship?

Authors:  Gert Jungbauer; Alexandra Stähli; Xilei Zhu; Lavinia Auber Alberi; Anton Sculean; Sigrun Eick
Journal:  Periodontol 2000       Date:  2022-03-04       Impact factor: 12.239

9.  Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity.

Authors:  Qing Meng; Qiuqiang Gao; Shebli Mehrazarin; Kamonchanok Tangwanichgapong; Yu Wang; Yiming Huang; Yutong Pan; Samuel Robinson; Ziwen Liu; Amirali Zangiabadi; Renate Lux; Panos N Papapanou; X Edward Guo; Harris Wang; Luke E Berchowitz; Yiping W Han
Journal:  EMBO Rep       Date:  2021-06-29       Impact factor: 9.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.